FMED
Fidelity Disruptive Medicine ETF · NAS
- Category Equity
- Expense Ratio 0.5%
- Listing Date Jun 12, 2023
- Volume 4,559.0
- Market Cap (AUM) $52.83M
Performance
+3.09%
1W
+0.47%
1M
-0.02%
3M
+18.79%
6M
+2.72%
YTD
-2.53%
1Y
Top Holdings
-
Name
Symbol%Assets
- Boston Scientific CorporationBSX6.17%
- UnitedHealth Group IncorporatedUNH4.05%
- Danaher CorporationDHR3.62%
- Centene CorporationCNC3.42%
- Intuitive Surgical, Inc.ISRG3.30%
- Alnylam Pharmaceuticals, IncALNY3.18%
- Insulet CorporationPODD3.04%
- Fidelity Revere Street Trust Central Cash Collateral FundN/A2.90%
- Inspire Medical Systems, Inc.INSP2.77%
- Exact Sciences CorporationEXAS2.52%
Technical Analysis of FMED 2024-05-03
Overview:
In analyzing the technical indicators for FMED over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for potential...
Recent News & Updates
Page 1 of 1
previousnext